Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital

Journal of the Medical Association of Thailand

Volumn 88, Issue 5, 2005, Pages 588-592

  Sanpavat, Suwimol ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Exchange transfusion; Kernicterus; Morbidity; Mortality; Neonatal hyperbilrubinemia

Indexed keywords

BILIRUBIN;

ANEMIA; APNEA; ARTICLE; BILIRUBIN BLOOD LEVEL; EXCHANGE BLOOD TRANSFUSION; FEMALE; GESTATIONAL AGE; HEART ARREST; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KERNICTERUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; PREMATURITY; RISK BENEFIT ANALYSIS; THAILAND; TREATMENT OUTCOME;

EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; RETROSPECTIVE STUDIES; THAILAND;

EID: 23044433545     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. th ed. Philadelphia: LW & W, 1999:765-819.
2. Phaosavasdi S, Uerpairojkit B, Thamkhantho M, Prugsapong C, Karnjanapitak A. Medical ethics on the year of neonatal jaundice campaign. J Med Assoc Thai 2004; 87: 1539-41.
3. Stevenson DK, Fanaroff AA, Maisels MJ, Young BWY, Wong RJ, Vreman HJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001; 108: 31-9.
4. Phuapradit W, Chaturachinda K, Auntlamai S. Risk Factors for neonatal hyperbiliribinemia. J Med Assoc Thai 1993; 76: 424-8.
5. Sanpavat S, Nuchprayoon I. Noninvasive transcutaneous bilirubin as a screening test to identify the need for serum bilirubin assessment. J Med Assoc Thai 2004; 87: 1193-8.
6. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6-14.
7. American Academy of Pediatrics, Provisional committee for quality improvement and subcommitte on hyperbilirubinemia. Practice parameter: Management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994; 94: 558-65.
8. Jackson JC. Adversed events associated with exchange transfusion in healthy and Ill newborns. Pediatrics 1997; 99: e7.
9. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990. J Pediatr 2004; 144: 626-31.
10. Sanpavat S. Neonatal Jaundice. In: Choteleosak V, Jongsrisawat B, Chatjatree P, Deerojvong J, Parbpal N, eds. Common pediatrics problems and treatment. Bangkok: Text and General Publication; 2002: 245-53.
11. Maisels MJ, Watchko JF. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2003; 88: F459-63.
12. Watchko JF, Maisels MJ. Jaundice in low birthweight infants: Pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed 2003; 88: F455-8.
13. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics 2003; 111: 1303-11.
14. Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 144: e130-53.
15. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med 2001; 344: 581-90.
16. Watchko J, Oski FA. Kernicterus in preterm newborns: Past, present, and future. Pediatrics 1992; 90: 707-15.